Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout

J&J pays Sail $785M, charting course to possible in vivo CAR-T buyout

  • July 30, 2026

Johnson & Johnson is cruising deeper into in vivo CAR-T waters, paying $785 million upfront to strike a deal that gives it the option to acquire Sail Biomedicines.

Leave A Comment

Fields (*) Mark are Required